Association of imaging abnormalities of the subcallosal septal area with Alzheimer's disease and mild cognitive impairment by Gan, C. L. et al.
lable at ScienceDirect
Clinical Radiology xxx (2017) 1e8Contents lists avaiClinical Radiology
journal homepage: www.cl inicalradiologyonl ine.netAssociation of imaging abnormalities of the
subcallosal septal area with Alzheimer’s disease
and mild cognitive impairment
C.L. Gan a,*, M.J. O’Sullivan b,c, C. Metzler-Baddeley b, S. Halpin a
aDepartment of Neuroradiology, University Hospital of Wales, Cardiff, UK
bCardiff University Brain Research Imaging Centre, School of Psychology, Cardiff, UK
cDepartment of Clinical Neuroscience, Institute of Psychiatry, King’s College London, London, UKarticle information
Article history:
Received 4 January 2017
Accepted 12 April 2017DOI of original article: http://dx.doi.org/10.10
* Guarantor and correspondent: C. L. Gan, Depa
University Hospital of Wales, Cardiff, UK. Tel.: þ4
02920743357.
E-mail address: cheelingan@yahoo.com (C.L. G
http://dx.doi.org/10.1016/j.crad.2017.04.021
0009-9260/ 2017 Published by Elsevier Ltd on beha
Please cite this article in press as: Gan CL, et a
mild cognitive impairment, Clinical RadioloAIM: To evaluate the use the distance between the adjacent septal nuclei as a surrogate
marker of septal area atrophy seen in Alzheimer’s disease (AD).
MATERIALS & METHODS: Interseptal distance (ISD) was measured, blind to clinical details, in
250 patients who underwent computed tomography (CT) of the brain at University Hospital of
Wales. Clinical details including memory problem history were retrieved. An ISD cut-off value
that discriminated those with and without memory symptoms was sought. ISD measurements
were also made in 20 AD patients. To test both the method and the deﬁned cut-off, mea-
surements were then made in an independent cohort of 21 mild cognitive impairment (MCI)
patients and 45 age-matched healthy controls, in a randomised and blinded fashion.
RESULTS: ISD measurement was achieved in all patients. In 28 patients with memory
symptoms, the mean ISD was 5.9 mm compared with 2.3 mm in those without overt symp-
toms (p¼0.001). The optimum ISD cut-off value was 4 mm (sensitivity 85.7% and speciﬁcity
85.8%). All AD patients had an ISD of >4 mm (mean ISD¼ 6.1 mm). The mean ISD for MCI
patients was 3.84 mm compared with 2.18 mm in age-matched healthy controls (p¼0.001).
Using a 4 mm cut-off correctly categorised 10 mild cognitive impairment patients (47.6%) and
38 healthy controls (84.4%).
CONCLUSION: ISD is a simple and reliable surrogate measurement for septal area atrophy,
applicable to CT and magnetic resonance imaging (MRI). It can be used to help select patients
for further investigation.
 2017 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.16/j.crad.2017.06.119.
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Alzheimer’s disease (AD) is the commonest cause
of dementia and it affects around 5.4 million people in the
US.1 Patients typically present with progressive memory
impairment and involvement of other cognitive domains or
skills, which impair social function and activities of daily
living.2 The diagnosis of AD is often difﬁcult especially near
the onset of symptoms. Recent diagnostic guidelines haveists.
ormalities of the subcallosal septal areawith Alzheimer’s disease and
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The majority of the neuroimaging research in AD has cen-
tred around mesial temporal lobe atrophy, which shows
volume loss in hippocampi, amygdala, entorhinal cortex,
and posterior cingulate cortex3e6; however, none of these
markers are straightforward to measure and evaluate and
many are suitable only for magnetic resonance imaging
(MRI). Very few studies have focused on the subcallosal grey
matter in relation to AD despite the fact that atrophy of this
region occurs early and is just as characteristic of AD.7
Although the imaging diagnosis for AD is difﬁcult,
various studies have shown that hippocampal or mesial
temporal lobe atrophy can be quantiﬁed by volumetric
MRI5,6 or visual rating methods8,9; however, volumetric
MRI requires rigorous standards for image acquisition and
analysis and is not suitable for routine clinical use. Thus far,
visual rating methods for measurement have been found to
be relatively insensitive for identifying mild AD or mild
cognitive impairment (MCI) and often introduce problems
of reliability especially when protocols are complex. An
increased cella media index has also been described in AD
patients, but is relatively non-speciﬁc and greatly inﬂu-
enced by the general atrophy state of the brain.10
It has been the authors’ clinical experience that atrophy
of the septal nuclei can commonly be seen in conditions
associated with hippocampal atrophy, principally in AD, but
also following head injury or in chronic alcohol excess. It
was hypothesised that a widening of the interseptal dis-
tance (ISD), deﬁned as the minimal distance between the
nuclei of each hemisphere, could act as a surrogate marker
for atrophy within core regions implicated in AD and other
memory disorders. This distance can be measured accu-
rately and easily on axial computed tomography (CT) or MRI
at the level of AC-PC (anterior commissure to posterior
commissure) line, as the distance between the medial
convexities of the septal nuclei, posterior to the anterior
cerebral arteries (Fig 1). It was hypothesised that by simple
measurement of the ISD, patients with memory disordersFigure 1 Axial T2-weighted image of an adult brain demo
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can be used as a simple but useful screening tool for AD.
Materials and methods
Assessment of normal variation of ISD within an
unselected hospital population
To observe the distribution of the ISD within a general
population, the ISDs in 250 consecutive patients who had
undergone CT of the brain were measured. The CT brain
protocol included axial imaging using a GE 750 Discover HD
(General Electric Healthcare Milwaukee, IL, USA) 64-slice
multidetector CT system of 2.5 mm sections from foramen
magnum to vertex (120 kV and 265 mA; 32 cm ﬁeld of view
[FOV]; allowing for a maximum of 2.3 noise factor; 860mGy
average dose). The CT examinations were requested either
by general practitioners or hospital doctors for a variety of
indications, but not speciﬁcally for the diagnosis of memory
disorder. All patients’ identiﬁable details were anonymised.
Patients with intracranial mass lesions, large infarcts
including the middle cerebral artery territory, and a history
of neurosurgery that might affect the ISD were excluded.
The measurements were done independently by an expe-
rienced neuroradiologist and a radiology trainee. Details
recorded from the request forms including patient’s age,
any known diagnosis of AD, dementia, MCI, history of
confusion or chronic memory problems as well as excess
alcohol use were then recorded after blinded measurement
of the ISD of these patients.
The measurements were then compared between the
two for reproducibility analysis by using the analysis of
variance method (ANOVA). Both inter-rater coefﬁcient of
variation and an intraclass correlation coefﬁcient were
calculated. The statistics were performed using the soft-
ware, SPSS 17.0 (SPSS, Chicago, IL, USA).
Using the measurements done by the neuroradiologist,
the range and mean of the ISD for patients with known AD,nstrating anatomical landmarks for ISD measurement.
ormalities of the subcallosal septal areawith Alzheimer’s disease and
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problems were compared with those without overt mem-
ory problems or history of excess alcohol use using inde-
pendent t-test. Using different cut-off values for the ISD, the
sensitivities and speciﬁcities were calculated and a receiver
operating characteristic curve was plotted. An optimal cut-
off value was then deﬁned based on the perceived best
combination of sensitivity and speciﬁcity.
Analysis of ISD in patients with known diagnosis of AD
To test the proposed cut-off value for the ISD, the ﬁrst 20
patients from a memory clinic database who had a diag-
nosis of AD were selected for ISD analysis. Identiﬁable de-
tails were removed and patients were anonymised for
analysis. All patients met criteria for probable AD based on
the National Institute of Neurological and Communicative
Disorders and Stroke and the Alzheimer’s Disease and
Related Disorders Association (NINCDS-ADRDA) criteria.11
“Probable AD” reﬂects the greatest degree of diagnostic
certainty that can be reached without neuropathology or
biopsy. Brieﬂy, all patients had (1) memory impairment and
impairment in at least one other domain on cognitive
testing; (2) signiﬁcant impairment of daily activities; (3)
evidence of progression over time. Recent proposed modi-
ﬁcations based on the use of neuroimaging were not
adopted.12 The aim was not to bias the evaluation of ISD by
selecting patients based on focal atrophy elsewhere, but to
test applicability in the widest sense. The Mini-Mental State
Examination scores of these patients ranged from 12 to 27.
In all patients, a routine CT brain was available from the
standard assessment within the memory clinic. All had
been reported in the normal way, noting, for example, white
matter lesions and evidence of previous infarction or brain
injury, but no volumetric or semi-quantitative assessments
of atrophy had been attempted. The ISD for each patient was
measured from the CT brain examination by an experienced
neuroradiologist.
Blinded analysis of MCI patients with age-matched
healthy control participants
To assess the value of ISDmeasurement in MCI, as well as
evaluating independence from similar measures of gener-
alised atrophy, a set of 66 datasets taken from a research
study investigating structural correlates of ageing and mild
cognitive impairment was also examined. These included
21 patients with MCI, and 45 age-matched healthy controls.
All were assessed by a single clinician. MCI was diagnosed
according to the Petersen criteria.13 All had a Clinical De-
mentia Rating score of 0.514 and memory impairment,
which was conﬁrmed by a score 1.5 standard deviations
below the age-corrected population mean for the memory
subscore of the Addenbroooke’s Cognitive Examination.15
Individuals were excluded if they had a known cause of
cognitive impairment other than the onset of neurodegen-
erative disease (e.g., previous head injury, neurological
disease, alcohol or substance abuse) and were also excluded
if they met diagnostic criteria for non-Alzheimer dementiaPlease cite this article in press as: Gan CL, et al., Association of imaging abn
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degeneration).
Healthy control participants, with an equivalent age
distribution, were recruited from the local community by
advertisements posted on the internet and in family
physician waiting rooms, newsletters, and mail shots.
Exclusion criteria included a history of neurological and/or
psychiatric disease, head injury, alcohol and/or drug abuse,
memory or other cognitive decline, stroke, large artery or
peripheral vascular disease, structural heart disease or heart
failure, and contraindications to MRI.
All individuals gave informed consent to take part in a
clinical, imaging, and cognitive study of mild cognitive
impairment. Ethical approval was provided by the South
East Wales Research Ethics Committee.
MR data were acquired using a 3 T GE HDx MRI system
(General Electric Healthcare). T1-weighted structural MRI
data were acquired using a three-dimensional (3D) fast
spoiled gradient recalled (FSPGR) echo sequence, acquired
with a matrix of 256256176, and ﬁeld of view of
256256176 mm, resulting in isotropic (1 mm) resolution
voxels. The timing parameters were TR/TE/TI ¼ 7.9/3/450
ms, and the ﬂip angle was 20o.
MRI images from all participants were reviewed and the
ISDs were measured by a single experienced neuroradiolo-
gist. Patients’ details including the underlying diagnosis were
blinded from the assessor. The minimum anterior and pos-
terior interhemispheric distances for each patient were also
measured at the bases of the frontal lobes and the occipital
lobes, respectively, as an indicator for the degree of general-
ised brain atrophy. The measurements for the MCI patients
and healthy control participants were compared by inde-
pendent t-test. The accuracy of ISD in identifyingMCI patients
was also assessed using the proposed cut-off value for ISD.Results
Assessment of normal variation of ISD within an
unselected hospital population
ISD measurement was achieved in all patients (median
age: 63 years, age range: 1e105 years, male: female ratio
(M:F) ¼ 1:1.2). Measurements were rated as difﬁcult in 11
patients. In six very young patients, the septal nuclei were
so close to each other that ISD could not be measured
accurately. The septal nuclei could not be located conﬁ-
dently in ﬁve patients as the anterior cerebral artery could
not be separated from the nuclei. To compensate for this
problem, after the independent assessment of ISD by the
neuroradiologist and trainee, the images from these 11
patients were reviewed together and a reasonable ISD was
agreed for each case.
The reproducibility analysis showed an inter-rater coef-
ﬁcient of variation of 10.5% and an intraclass correlation
coefﬁcient of 0.96 when the measurements of ISD were
compared between the neuroradiologist and trainee. This
shows that ISD measurement is highly reproducible be-
tween assessors irrespective of clinical experience.ormalities of the subcallosal septal areawith Alzheimer’s disease and
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patients where a known diagnosis of AD, dementia, MCI,
history of confusion, or chronic memory problems had been
noted on the request forms for the CT examination. The
mean ISD for these patients was 5.9 mm (2.7e11 mm).
There were 11 patients with a history of excess alcohol use
stated on the CT brain request forms and the mean ISD for
them was 4 mm (2.2e6.4 mm). The remaining 211 patients
were considered a control group without overt memory
disorders likely to reﬂect the general population. The mean
ISD in this group was 2.3 mm (0.8e9 mm). There was
relatively little variation in ISD with advancing age. The
mean ISD for both those with noted memory difﬁculties,
and those with noted excess alcohol use, differed from the
“control” population in which neither was mentioned
(p¼0.001 for patient group with memory problems and
p¼0.002 for patient group with excess alcohol use; Fig 2).
The receiver operating characteristic curve (Fig 3) plotted
with sensitivities and speciﬁcities of using cut-off values for
ISD from 2.5 to 7 mm shows that ISD measurement has a
good predictive power for patients with memory problems.
A ISD cut-off of 4 mm gives a sensitivity of 85.7% and a
speciﬁcity of 85.7%.
Analysis of ISD in patients with known diagnosis of AD,
MCI, and age-matched healthy controls
ISD measurement was achieved in all 85 patients,
including 20 AD patients (median age: 85 years, age range:
74e90 years, M:F¼1:2.2), 21 MCI patients (median age: 78
years, age range: 58e90 years, M:F¼1.3:1) and 45 healthyFigure 2 Differences of ISD between the general population an
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M:F¼ 1.1:1). The ISD measurement was difﬁcult in two
patients where there were some movement artefacts
affecting the resolution of the MRI images; however,
reasonable measurements were noted for these two pa-
tients, and therefore, the results were still included in the
study.
The mean ISD for the different patient groups was: AD
patients: 6.1 mm (4e8.1 mm); MCI patients: 3.84 mm (1e7
mm) and healthy controls: 2.18 mm (1e6.2 mm; Fig 4) The
mean ISDs of both AD (based on CT) andMCI (based onMRI)
groups were higher than that of the healthy control
(p<0.001 for both comparisons).
The differences in ISD between the MCI patients and the
healthy controls appear to be independent of the degree of
age-related generalised atrophy of the brain as no statisti-
cally signiﬁcant differences can be demonstrated on the
means of anterior and posterior interhemispheric distances
(Table 1). Using 4mm as a cut-off value, 10 MCI patients and
38 healthy controls were identiﬁed correctly (sensitivity
47.6%, speciﬁcity 84.4%), whereas, all AD patients invariably
had an ISD of 4mm.Discussion
The septal area forms part of the basal forebrain cholin-
ergic complex and is an important anterior component of
the limbic system. It is located on the medial surface of the
cerebral hemisphere nestled inferior to the rostrum of the
corpus callosum and anterior to the third ventricle andd patients with memory problems and excess alcohol use.
ormalities of the subcallosal septal areawith Alzheimer’s disease and
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Figure 3 Receiver operating characteristic curve for using ISD to discriminate patients with memory problems from general population.
Figure 4 Sagittal T2-weighted image of an adult brain demonstrating the anatomy of the septal area.
C.L. Gan et al. / Clinical Radiology xxx (2017) 1e8 5lamina terminalis. It contains two nearly vertically oriented
gyri, the subcallosal area, and the smaller paraterminal
gyrus (Fig 4). The septal nuclei are subcortical grey matter
nuclei deep to the septal area.16 Volume loss of the limbicPlease cite this article in press as: Gan CL, et al., Association of imaging abn
mild cognitive impairment, Clinical Radiology (2017), http://dx.doi.org/1structures and severe loss of cortical cholinergic innerva-
tion are strongly associated with AD. As the septal area is
contiguous with the limbic structures, extending from the
temporal lobe, volume loss of limbic structures also affectsormalities of the subcallosal septal areawith Alzheimer’s disease and
0.1016/j.crad.2017.04.021
Table 1
Differences in means of inter-septal, and anterior and posterior intermi-
spheric distances.
MCI
(n¼21)
Controls
(n¼45)
p-Value
Inter-septal distance (mm) 3.841.90 2.181.39 0.001
Anterior interhemispheric
distance (mm)
1.250.42 1.100.22 0.66
Posterior interhemispheric
distance (mm)
1.160.32 1.090.22 0.36
C.L. Gan et al. / Clinical Radiology xxx (2017) 1e86the septal area. In AD patients, the greatest percentage
volumetric loss had been shown to occur in the septal area
compared to other limbic structures including the hippo-
campus, amygdala, parahippocampal cortex, and posterior
cingulate cortex.7 MRI-co-registered HMPAO SPET exami-
nations of the brain have shown reduced perfusion in the
septal area, as well as other limbic structures in AD pa-
tients.17 Septal area atrophy can be appreciated on axial CT
or MRI as ﬂattening of the normal medial convexity of the
septal nuclei, which results in widening of ISD.
Although measurement of the ISD is straightforward and
reproducible, it does require reasonably thin axial sections
on CT and MRI. On 2.5 mm sections, the cistern of the
lamina terminalis posteriorly, and anterior cerebral artery
branches anteriorly, and the anterior paraolfactory sulcus
are identiﬁed. The septal nuclei then appear as medial
convexities. In the normal patient, the CSF space connecting
the cistern and the sulcus is thin, and resembles a dumbbell
or narrow-stemmed wine glass (Fig 1). In the abnormal
case, the CSF space is widened, in contrast to the anterior
and posterior interhemispheric ﬁssures and resembles a
tumbler. With a little practice, widening of the ISD can be
easily identiﬁed by both radiologists and clinicians, in
routine reviewing of neuroimaging scans. Fig 5 is an
example of marked ISD widening, but with closely opposed
medial frontal lobes.
To the authors’ knowledge, this is the ﬁrst study to
demonstrate a simple, quick, and reliable surrogate markerFigure 5 Axial CT and MRI (T2-weighted) brain images of an ad
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degenerative states seen in AD and MCI. The results
conﬁrmed the study hypothesis that AD and MCI patients
have a signiﬁcantly wider ISD. This would correspond to
previous studies that have shown focal atrophy of related
“limbic” grey matter regions in AD patients.3,7 Furthermore,
the widened ISD is speciﬁc and is relatively independent of
age-related cerebral atrophy or small vessel ischaemic
damage seen in older patients.
Although the measurements were done using different
imaging techniques, the ISD, in general, was wider in AD
patient, than MCI patients. Therefore, by using a cut-off
value of 4 mm, more AD patients than MCI patients were
identiﬁed correctly. The results were similar to MRI volu-
metric studies showing greater hippocampal volume loss in
AD patients to MCI patients.18,19 The variation of ISD in MCI
patients was probably due to the known heterogeneity of
MCI. This category includes patients who progress quickly
to AD, as well as others who remain stable or who have an
alternative disease, which, in some cases, will spare the
septal region.20 This is further conﬁrmed by the greater
hippocampal atrophy seen in MCI patients who progress
quickly to AD than those who do not progress to AD.21 It is
speculated that ISD may help in predicting those patients
who will progress to AD.
Differential atrophy in the hippocampal subﬁelds by
using a automated segmentation software has been
described in a recent study which allows better detection of
MCI, compared to conventional mesiotemporal volume-
try.22 However, in this study, we have proposed a quicker
and easier quantitative method of identifying AD and MCI
which can be used in routine examination, and not only in
MRI but also in CT. In many healthcare settings, MRI is less
easily accessible than CT, and so there are advantages in
having a quick and simple method that can be equally well
applied to CT and MRI.
Other measurements, such as the cella media index, have
been described as being useful in AD patients. These relate
the width of mesial temporal structures to the width of theult with established AD showing abnormally widened ISD.
ormalities of the subcallosal septal areawith Alzheimer’s disease and
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rophy.10 The ISD is more speciﬁc, being a more direct marker
of atrophy of affected nuclei; however, it is interesting to
speculate on exactly why the ISD is increased in AD.Without
a direct volumetric study of the septal area, the increasing
distance directly reﬂects atrophy of the septal nuclei; how-
ever, the adjacent brain is intimately involved with memory.
For example, the substantia innonimata is directly adjacent
to the septal nuclei, and atrophy of the substantia innomi-
nata and nucleus of Meynert has been described in AD, with
an imaging correlation on MRI.23,24 It is therefore probably
an over-simpliﬁcation to claim that the association of the
imaging observation of a widened ISD is entirely due to loss
of neurons conﬁned to the septal nuclei. It is more likely that
the observed widening reﬂects a somewhat more general-
ised regional atrophy of memory-related cholinergic neu-
rons. The message contained within this paper is that a
simple observation, made on routine CT, can identify a large
percentage of patients with AD or who are at risk of devel-
oping AD. The negative ﬁnding is just as important: no pa-
tients in the present study with an ISD of <4 mm had AD.
Most patients with a large ISD (>5 mm) also had char-
acteristic CT ﬁndings of enlarged temporal horns, and
mesial temporal thinning: these patients are usually
straightforward to assess by conventional imaging tech-
niques; however, it is a common and reassuring observation
in daily clinical practice to look at the ISD in patients where
the mesial temporal lobes are equivocal on routine CT.
The main limitation of the present study is lack of his-
topathological veriﬁcation. Although different studies have
shown septal area atrophy in AD patients, the ISD is not a
direct volumetric measurement for the septal area, but a
surrogate measurement for it. The cross-sectional area of
the nuclei or the height of the medial convexity could be
measured directly on axial scans, but these measurements
would be more complex, time-consuming, prone to inter-
observer error, and would convey no additional useful
measurement compared to ISD measurement. Further
research to correlate the ISD with hippocampal and septal
area volume in AD and MCI patients has been initiated as a
continuation of this study to establish their relationship and
to compare superiority of tests.
The other limitation to the present study was that a full
medical history for every patient was not obtained in the
initial patient group to observe the variation of ISD in the
general population. Memory problems may have been
underdiagnosed among these patients as the authors relied
solely on the information written in the request forms for
the CT brain examination. The referring clinicians might not
have included the relevant details of the patients’ memory
state and so patients with memory problems may have
been included within the study’s normal range. It was also
assumed that patients with any chronic memory problems
have a wider ISD than the normal controls; however, a
major strength of this study is that this is based in a large
and realistic hospital population. Furthermore, by using a
cut-off ISD value suggested from the assessment of ISD in
the initial patient group, patients with AD and MCI could be
differentiated from healthy controls. Of course, there isPlease cite this article in press as: Gan CL, et al., Association of imaging abn
mild cognitive impairment, Clinical Radiology (2017), http://dx.doi.org/1some overlap between the groups, particularly between the
MCI and the AD patients; however no AD patient had an ISD
of <4 mm. The cut-off for ISD may be different for varying
population groups, and determination of a more accurate
population based cut-off value will require further studies
on larger but different population groups.
ISD measurement is a cheap, simple, reliable, and easily
reproducible method to measure septal area atrophy as a
marker for neurodegenerative states seen in patients with
memory problems. It can be used as a simple but valuable
tool to differentiate patients with memory problems, in
particular AD and MCI, from the normal population, with
reasonable accuracy. Widening of the ISD can be easily
recognised by both clinicians and radiologists, not only in
MRI but also in routine CT brain scans. Use of ISD in routine
reporting can act as useful screening test for AD and MCI,
and help select patients for further investigations, so that
diagnosis can be achieved at an earlier stage.Acknowledgements
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